Author:
Darwish Hany W.,Bakheit Ahmed H.,Al-Shakliah Nasser S.,Darwish Ibrahim A.
Funder
Deanship of Scientific Research
Subject
Spectroscopy,Instrumentation,Atomic and Molecular Physics, and Optics,Analytical Chemistry
Reference33 articles.
1. Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase;Ciardiello;Clin. Cancer Res.,2003
2. ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration;Wedge;Cancer Res.,2002
3. Vandetanib for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease: U.S. Food and Drug Administration drug approval summary;Thornton;Clin. Cancer Res.,2012
4. Vandetanib as a potential new treatment for ER negative breast cancers;Marangoni;Cancer Res.,2015
5. Chemotherapy plus vandetanib or chemotherapy alone in advanced non-small cell lung cancer: a meta-analysis of four randomised controlled trials;Xiao;Clin. Oncol.,2013
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献